IHL 0.00% 4.1¢ incannex healthcare limited

Novotechs' full clinical analysis of 42X?Q2 all but upon us we...

  1. 4,375 Posts.
    lightbulb Created with Sketch. 8461
    Novotechs' full clinical analysis of 42X?

    Q2 all but upon us we can look forward to the full clinical study report on 42X arriving and revealing the IHL 42X patient dose comparisons = differentiated dose strengths and endpoint analysis


    any day I suspect smile.png
 
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.